InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,468.40
(
0.28%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.51
(
0.46%
)
Bitcoin
64,922.13
(
1.44%
)
Post# of 363711
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jimmybob

Send PM Follow Ignore
Followers 1880
Posts 137558
Boards Moderated 5
Alias Born 01/03/2007

jimmybob

Re: None

Friday, 12/19/2014 6:29:41 AM

Friday, December 19, 2014 6:29:41 AM

Post# of 363711
Intercept price target lowered to $475 from $693 at Citigroup
Citigroup lowered its price target for Intercept shares to $475 on expectations investor concerns around the company's liver fibrosis drug, OCA, will persist. Citi, however, says it remains a buyer of the stock. It believes the level of concern around OCA’s cholesterol effect is overdone. The firm keeps a Buy rating on shares of Intercept

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up